Laboratoire de Biochimie Pharmaceutique-FMPO, Université Cheikh Anta Diop, Dakar, Sénégal.
Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Equipe "Biologie vasculaire et du globule rouge", Université Claude Bernard Lyon 1, COMUE, Lyon, France.
Pediatr Blood Cancer. 2019 Oct;66(10):e27934. doi: 10.1002/pbc.27934. Epub 2019 Jul 19.
Our objective was to investigate the combined and differential effects of alpha-thalassemia -3.7 kb deletion and HbF-promoting quantitative trait loci (HbF-QTL) in Senegalese hydroxyurea (HU)-free children and young adults with sickle cell anemia (SCA).
Steady-state biological parameters and vaso-occlusive crises (VOC) requiring emergency admission were recorded over a 2-year period in 301 children with SCA. The age of the first hospitalized VOC was also recorded. These data were correlated with the alpha-globin and HbF-QTL genotypes. For the latter, three different genetic loci were studied (XmnI, rs7482144; BCL11A, rs1427407; and the HBS1L-MYB region, rs28384513) and a composite score was calculated, ranging from zero (none of these three polymorphisms) to six (all three polymorphisms at the homozygous state).
A positive clinical impact of the HbF-QTL score on VOC rate, HbF, leucocytes, and C-reactive protein levels was observed only for patients without alpha-thalassemia deletion. Conversely, combination of homozygous -3.7 kb deletion with three to six HbF-QTL was associated with a higher VOC rate. The age of the first hospitalized VOC was delayed for patients with one or two alpha-thalassemia deletions and at least two HbF-QTL.
Alpha-thalassemia -3.7 kb deletion and HbF-QTL are modulating factors of SCA clinical severity that interact with each other. They should be studied and interpreted together and not separately, at least in HU-free children.
我们的目的是研究α-地中海贫血-3.7kb 缺失与血红蛋白 F 促进的数量性状位点(HbF-QTL)在无羟基脲(HU)治疗的塞内加尔镰状细胞贫血(SCA)儿童和青年中的联合和差异作用。
在 301 例 SCA 患儿中,记录了 2 年期间的稳态生物学参数和需要急诊入院的血管阻塞性危象(VOC)。还记录了首次住院 VOC 的年龄。这些数据与α-珠蛋白和 HbF-QTL 基因型相关。对于后者,研究了三个不同的遗传位点(XmnI、rs7482144;BCL11A、rs1427407;以及 HBS1L-MYB 区域,rs28384513),并计算了一个复合评分,范围从 0(这三种多态性均不存在)到 6(所有三种多态性均为纯合状态)。
仅在无α-地中海贫血缺失的患者中,HbF-QTL 评分对 VOC 发生率、HbF、白细胞和 C 反应蛋白水平有积极的临床影响。相反,纯合-3.7kb 缺失与三种至六种 HbF-QTL 联合与更高的 VOC 发生率相关。对于有一个或两个α-地中海贫血缺失和至少两个 HbF-QTL 的患者,首次住院 VOC 的年龄延迟。
α-地中海贫血-3.7kb 缺失和 HbF-QTL 是 SCA 临床严重程度的调节因素,它们相互作用。至少在无 HU 治疗的儿童中,它们应该一起而不是分开进行研究和解释,而不是分开进行。